132 related articles for article (PubMed ID: 8804450)
21. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
[TBL] [Abstract][Full Text] [Related]
22. Medulloblastoma in adults: treatment results and prognostic factors.
Abacioglu U; Uzel O; Sengoz M; Turkan S; Ober A
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):855-60. PubMed ID: 12377339
[TBL] [Abstract][Full Text] [Related]
23. The prognostic significance of glial fibrillary acidic protein staining in medulloblastoma.
Goldberg-Stern H; Gadoth N; Stern S; Cohen IJ; Zaizov R; Sandbank U
Cancer; 1991 Aug; 68(3):568-73. PubMed ID: 2065277
[TBL] [Abstract][Full Text] [Related]
24. Anaplasia is rare and does not influence prognosis in adult medulloblastoma.
Giordana MT; D'Agostino C; Pollo B; Silvani A; Ferracini R; Paiolo A; Ghiglione P; Chiò A
J Neuropathol Exp Neurol; 2005 Oct; 64(10):869-74. PubMed ID: 16215458
[TBL] [Abstract][Full Text] [Related]
25. Are childhood and adult medulloblastomas different? A comparative study of clinicopathological features, proliferation index and apoptotic index.
Sarkar C; Pramanik P; Karak AK; Mukhopadhyay P; Sharma MC; Singh VP; Mehta VS
J Neurooncol; 2002 Aug; 59(1):49-61. PubMed ID: 12222838
[TBL] [Abstract][Full Text] [Related]
26. Atypical teratoid/rhabdoid tumor of the central nervous system: a comparative study with primitive neuroectodermal tumor/medulloblastoma.
Ho DM; Hsu CY; Wong TT; Ting LT; Chiang H
Acta Neuropathol; 2000 May; 99(5):482-8. PubMed ID: 10805090
[TBL] [Abstract][Full Text] [Related]
27. Tumor cell proliferation and apoptosis in medulloblastoma.
Schiffer D; Cavalla P; Chiò A; Giordana MT; Marino S; Mauro A; Migheli A
Acta Neuropathol; 1994; 87(4):362-70. PubMed ID: 7912469
[TBL] [Abstract][Full Text] [Related]
28. Small intestinal stromal tumors: a clinicopathologic study of 20 cases with immunohistochemical assessment of cell differentiation and the prognostic role of proliferation antigens.
Ma CK; De Peralta MN; Amin MB; Linden MD; Dekovich AA; Kubus JJ; Zarbo RJ
Am J Clin Pathol; 1997 Dec; 108(6):641-51. PubMed ID: 9384445
[TBL] [Abstract][Full Text] [Related]
29. Cell kinetic study of thymic epithelial tumors using PCNA (PC10) and Ki-67 (MIB-1) antibodies.
Yang WI; Efird JT; Quintanilla-Martinez L; Choi N; Harris NL
Hum Pathol; 1996 Jan; 27(1):70-6. PubMed ID: 8543314
[TBL] [Abstract][Full Text] [Related]
30. Immunocytochemical detection of cell proliferation-related antigens in cytologic smears of human malignant neoplasms using PC10, reactive with proliferating cell nuclear antigen, and Ki-67. A comparative study.
Pelosi G; Bresaola E; Manfrin E; Rodella S; Schiavon I; Iannucci A
Arch Pathol Lab Med; 1994 May; 118(5):510-6. PubMed ID: 7910728
[TBL] [Abstract][Full Text] [Related]
31. Is medulloblastoma the same tumor in children and adults?
Giordana MT; Cavalla P; Dutto A; Borsotti L; Chiò A; Schiffer D
J Neurooncol; 1997 Nov; 35(2):169-76. PubMed ID: 9266455
[TBL] [Abstract][Full Text] [Related]
32. Proliferating cell nuclear antigen and Ki-67 labeling in hepatocellular nodules: a comparative study.
Tiniakos DG; Brunt EM
Liver; 1999 Feb; 19(1):58-68. PubMed ID: 9928768
[TBL] [Abstract][Full Text] [Related]
33. Proliferating cell nuclear antigen and MIB-1. An alternative to classic prognostic indicators in renal cell carcinomas?
Haitel A; Wiener HG; Migschitz B; Marberger M; Susani M
Am J Clin Pathol; 1997 Feb; 107(2):229-35. PubMed ID: 9024073
[TBL] [Abstract][Full Text] [Related]
34. MDM2 overexpression is associated with short survival in adults with medulloblastoma.
Giordana MT; Duó D; Gasverde S; Trevisan E; Boghi A; Morra I; Pradotto L; Mauro A; Chió A
Neuro Oncol; 2002 Apr; 4(2):115-22. PubMed ID: 11916503
[TBL] [Abstract][Full Text] [Related]
35. Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas. Prognostic significance.
Kirkegaard LJ; DeRose PB; Yao B; Cohen C
Am J Clin Pathol; 1998 Jan; 109(1):69-74. PubMed ID: 9426520
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors in medulloblastoma.
Chin HW; Maruyama Y
Am J Clin Oncol; 1982 Aug; 5(4):359-69. PubMed ID: 6810689
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis.
Zhao F; Zhang J; Li P; Zhou Q; Zhang S; Zhao C; Wang B; Yang Z; Li C; Liu P
J Neurooncol; 2018 Sep; 139(2):333-340. PubMed ID: 29687281
[TBL] [Abstract][Full Text] [Related]
38. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
Saeger W; Lüdecke B; Lüdecke DK
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
[TBL] [Abstract][Full Text] [Related]
40. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
Narita T; Funahashi H; Satoh Y; Takagi H
Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]